CUSIP: 89620X506
Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,683,504
-
Share change
-
-309,791
-
Total reported value
-
$2,198,019
-
Price per share
-
$0.33
-
Number of holders
-
15
-
Value change
-
-$325,259
-
Number of buys
-
4
-
Number of sells
-
11
Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q2 2019
As of 30 Jun 2019,
TRILLIUM THERAPEUTICS INC - COM NEW was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,683,504 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, NEA Management Company, LLC, MORGAN STANLEY, BAKER BROS. ADVISORS LP, Tekla Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, Samsara BioCapital, LLC, Coastal Investment Advisors, Inc., TWO SIGMA INVESTMENTS, LP, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.